Deals
CVC Explores Options for €11 Billion Drugmaker Recordati
- Buyout firm is in early stages of studying possible exit
- Recordati shares have outperformed peers in past year
This article is for subscribers only.
CVC Capital Partners is exploring options for its controlling stake in Italian drugmaker Recordati SpA, according to people familiar with the matter.
The buyout firm is working with advisers and is in the early stages of studying alternatives including a potential sale or a combination with another business, the people said. It’s informally reaching out to some potential buyers to gauge their interest in a deal, the people said, asking not to be identified because the information is private.